Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and potential health benefits.

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

A WOMAN who used to fear getting stuck in restaurant chairs due to her weight has now lost eight stone after forking out on ...

April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Eli Lilly reported promising results from a study of ... That was less than a year after Ozempic won approval to treat diabetes, and before the weight-loss effects of this class of drugs had ...

Eli Lilly saw its shares jump by 15% on Thursday after unveiling positive results from a clinical trial ... and the higher-dose weight-loss variant Wegovy, slipped 3.9% amid concerns that a ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment Wegovy ... share price for Novo. Before the release of Novo's CagriSema ...

A DAD once nicknamed “Fat Pal” by his friends has dropped five stone in five months after using Mounjaro. Sean Burns, 32, from Glasgow, said he has “struggled with excess weight” his whole life ...

You can use Wegovy ... results to expect with Wegovy, talk with your doctor. In clinical trials, most people taking 1.7-mg and 2.4-mg doses of Wegovy had lost 5% to 15% of their body weight after ...

But, like all medications, there are side effects to using both Ozempic and Mounjaro with several celebrities sharing their ...